Invokana
/
Invokana (canagliflozin) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated for the treatment of type 2 diabetes mellitus. It is administered as an oral tablet and is available by prescription. Patients are advised that Invokana may increase the risk of lower limb amputations and should not be used in patients with severe renal impairment or end-stage renal disease.
FAQs about Invokana
What should I do if I miss a dose?
If you miss a dose of Invokana (canagliflozin), take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I take Invokana while pregnant or breastfeeding?
The use of Invokana during pregnancy is not recommended, as it may harm the fetus. If you are pregnant or planning to become pregnant, discuss this with your healthcare provider. It is not known if canagliflozin passes into breast milk, so breastfeeding while taking Invokana should be discussed with your healthcare provider. This information is found in the Warnings and Precautions section of the label.
Can I stop taking Invokana suddenly?
It is not recommended to stop taking Invokana suddenly without consulting your healthcare provider. Abrupt discontinuation may affect your blood sugar control. Always discuss any changes to your medication regimen with your prescriber. This guidance is included in the Warnings and Precautions section of the label.
How should I store Invokana?
Invokana should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children. This storage information is specified in the Storage section of the label.
25
commonly-prescribed
medication.